Abstract:Hepatocellular carcinoma (HCC) is one of the most prevalent malignant neoplasms. Current treatments for HCC, such as tyrosine kinase inhibitors, have limited efficacy, highlighting the urgent need for better therapies. Immunotherapies, including anti-programmed death receptor 1 (PD-1) and anti-Cytotoxic T-lymphocyte associated protein 4 (CTLA-4), and more recently, the combination of anti-PD-L1 and anti-vascular endothelial growth factor (VEGF) monoclonal antibodies, have shown efficacy against HCC, resulting in Food and Drug Administration (FDA) approval. However, these immunotherapies only show efficiency in a small proportion of patients, meaning there is a great need to improve and optimize treatments against HCC. Accurate animal models that mimic human HCC are necessary to help better understand the nature of these tumors, which in turn will allow the development and testing of new treatments. Existing pre-clinical HCC models can be divided into non-genetic and genetic models. Non-genetic models involve implanting human or murine HCC cell lines or inducing tumors using chemical compounds or dietary modifications. These models have limitations, including slow tumor development and a lack of resemblance to human HCC. Genetic models, on the other hand, manipulate gene expression to induce HCC in mice and provide a better understanding of the effects of specific genes on tumor development. One method commonly used to generate HCC is hydrodynamic tail vein injection (HTVI), which consists of the delivery of oncogenes directly to the liver, resulting in expression and subsequent hepatocyte transformation. Usually, Sleeping Beauty transposase-containing plasmids are used to achieve stable and long-term gene expression. Once the HCC tumor is generated, and a proper tumor microenvironment (TME) is established, it is important to study the immune compartment of the TME, which plays a crucial role in HCC development and response to treatment. Techniques like flow cytometry can be used to analyze the immune cell populations in HCC tumors and assess their impact on tumor development and survival in mice. In this article, we thoroughly describe an example of the methodology to successfully generate HCC murine models via HTVI, and we propose a way to characterize the immune TME by flow cytometry.

Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging

Construction of mouse model of liver implanted tumor after hepatectomy

Establishment of xenograft mouse models for studying human hepatocellular carcinoma by using vivo imaging system

Establishment and characteristic of an orthotopic implantation model of human hepatocellular carcinoma with Luc-GFP-labeled in nude mice

Establishment of the animal model with human hepatoma cell labelled with luciferase

Establishment of a Metastatic Model of Human Hepatocellular Carcinoma in Nude Mice Via Orthotopic Implantation of Histologically Intact Tissues

Non‐invasive in Vivo Imaging for Liver Tumour Progression Using an Orthotopic Hepatocellular Carcinoma Model in Immunocompetent Mice

Establishment of an Intrahepatic Xenograft Tumor Model in Nude Mice and Its Detection by in Vivo Fluorescence Imaging System

Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors

The establishment of a systematic site-specific metastasis model of human hepatocellular carcinoma in nude mouse

Establishment of a murine hepatocellular carcinoma model by hydrodynamic injection and characterization of the immune tumor microenvironment

Establishment of a High Metastatic Potential Human Hepatocellular Carcinoma Orthotopic Transplantation Model with Palliative Liver Resection in Nude Mice

Metastatic Human Hepatocellular Carcinoma Models in Nude Mice and Cell Line with Metastatic Potential

Establishment of a Dual-Color Fluorescence Tracing Orthotopic Transplantation Model of Hepatocellular Carcinoma.

A Nude Mouse Model of Orthotopic Liver Transplantation of Human Hepatocellular Carcinoma HCCLM3 Cell Xenografts and the Use of Imaging to Evaluate Tumor Progression

A Novel Xenograft Model of Human Hepatocellular Carcinoma in Immunocompetent Mice Based on the Microcarrier-6.

The Establishment of Metastatic Human Hepatocellular Carcinoma Orthotopic Transplantation Model in Combination with Hepatic Artery Ligation in Nude Mice

Establishment of an Orthotopic Transplantation Tumor Model of Hepatocellular Carcinoma in Mice.

A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma

A Novel Mouse Model for Liver Metastasis of Prostate Cancer Reveals Dynamic Tumour-Immune Cell Communication.

Establishment of image-guided radiotherapy of orthotopic hepatocellular carcinoma mouse model